We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INHD:NASDAQInno Holdings Inc. Analysis

Data as of 2026-06-17 - not real-time

$39.49

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Inno Holdings (INHD) has surged to $39.49 amid a speculative AI partnership and a $60 million at‑the‑market equity offering, but the technical backdrop is frazzled. The 14‑day RSI sits at an extreme 95 points, flagging an overbought condition, while the MACD remains bullish yet modest (line 9.87 vs. signal 6.08). Short‑term price support hovers near $1.01, and the 30‑day volatility exceeds 1,000 %, underscoring a wildly erratic price path. Fundamentally, the company reports negative operating margins (‑84.97 %) and a trailing EPS of ‑$76.80, with no dividend and a price‑to‑sales ratio above 39×, suggesting severe valuation disconnect.
The balance sheet shows ample cash ($31.97 M) against modest debt ($0.18 M), yet cash flow is deeply negative (operating cash flow ‑$9.55 M). The stock’s beta of 2.6 and a historic max drawdown of ‑99.98 % amplify downside risk, while the sector (basic materials/steel) typically offers limited growth upside. The recent AI deal and reverse‑split activity have driven a short‑term rally, but dilution risk from the AT‑M offering and ongoing profitability concerns make the long‑term outlook tenuous.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Extreme RSI indicating overbought conditions
  • Dilution risk from the $60 M AT‑M equity offering
  • Recent AI partnership driving speculative price spikes

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Continued cash burn and negative earnings
  • Potential operational improvements from AI initiative
  • High beta and volatility limiting stable returns

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Persistent negative profitability and cash flow
  • Lack of sustainable dividend or earnings growth
  • Historical near‑total drawdown and speculative market behavior

Key Metrics & Analysis

Financial Health

Revenue Growth94.90%
Profit Margin-86.84%
ROE-14.70%
ROA-8.75%
Debt/Equity0.38
P/B Ratio0.4
Op. Cash Flow$-9554644
Free Cash Flow$-8197950

Technical Analysis

TrendNeutral
RSI95.1
Support$1.01
Resistance$43.37
MA 20$14.64
MA 50$7.54
MA 200$345.45
MACDBullish
VolumeIncreasing
Fear & Greed Index92.18

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.61
Volatility1062.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.